Literature DB >> 1362079

A new restriction fragment length polymorphism of the human TNF-B gene detected by AspHI digest.

S Ferencik1, M Lindemann, B Horsthemke, H Grosse-Wilde.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1362079     DOI： 10.1111/j.1744-313x.1992.tb00086.x

Source DB:  PubMed          Journal:  Eur J Immunogenet        ISSN： 0960-7420


× No keyword cloud information.
  6 in total

Review 1.  Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis.

Authors:  C L Verweij
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

3.  Genetic markers in clinically well defined patients with ulcerative colitis (UC).

Authors:  G Bouma; J B Crusius; M A García-González; B U Meijer; H P Hellemans; R J Hakvoort; G M Schreuder; P J Kostense; S G Meuwissen; A S Peña
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans.

Authors:  J Wattavidanage; R Carter; K L Perera; A Munasingha; S Bandara; D McGuinness; A R Wickramasinghe; H K Alles; K N Mendis; S Premawansa
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

5.  Linkage of inflammatory bowel disease to human chromosome 6p.

Authors:  J Hampe; S H Shaw; R Saiz; N Leysens; A Lantermann; S Mascheretti; N J Lynch; A J MacPherson; S Bridger; S van Deventer; P Stokkers; P Morin; M M Mirza; A Forbes; J E Lennard-Jones; C G Mathew; M E Curran; S Schreiber
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).

Authors:  G Bouma; B Xia; J B Crusius; G Bioque; I Koutroubakis; B M Von Blomberg; S G Meuwissen; A S Peña
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.